Study, published in The Lancet Respiratory Medicine, has revealed that a drug called benralizumab - administered as an ...

Every 30 seconds, someone in the world will experience a flare-up of their asthma or chronic obstructive pulmonary disease ...

The study, called the ABRA trial, was led by King’s College London researchers and published in The Lancet Respiratory ...

London scientists have created a “game-changing” new treatment for asthma attacks that can reduce the need for further ...

Benralizumab is what’s known as a monoclonal antibody, which replicates properties of a normal antibody produced by the ...

It is already used as a recurring treatment for severe asthma in low doses. However, the trial found that a single higher ...

The first new treatment for asthma attacks in 50 years is a drug already available—and it’s 4x more effective than steroid ...

A UK study has shown that a drug currently used to treat severe asthma could be re-purposed for use in emergency settings, ...

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung ...

Geoffrey Pointing says its hard to describe the distress of an asthma or COPD flare-up.“Honestly, when you're having ...